Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
dc.contributor.author | Dizdarevic, S.![]() |
|
dc.contributor.author | Tulchinsky, M.![]() |
|
dc.contributor.author | McCready, V.R.![]() |
|
dc.contributor.author | Mihailovic, J,![]() |
|
dc.contributor.author | Vinjamuri, S.![]() |
|
dc.contributor.author | Buscombe, J.R.![]() |
|
dc.contributor.author | Lee, S.T.![]() |
|
dc.contributor.author | Frangos, S.![]() |
|
dc.contributor.author | Sathekge, Mike Machaba![]() |
|
dc.contributor.author | Siraj, Q.![]() |
|
dc.contributor.author | Choudhury, P.![]() |
|
dc.contributor.author | Bom, H.![]() |
|
dc.contributor.author | Franceschi, M.![]() |
|
dc.contributor.author | Ugrinska, A.![]() |
|
dc.contributor.author | Paez, D.![]() |
|
dc.contributor.author | Hussain, R.![]() |
|
dc.contributor.author | Mailman, J.![]() |
|
dc.contributor.author | Luster, M.![]() |
|
dc.contributor.author | Virgolini, I.![]() |
|
dc.date.accessioned | 2020-09-10T06:09:31Z | |
dc.date.available | 2020-09-10T06:09:31Z | |
dc.date.issued | 2019-04 | |
dc.description.abstract | The World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) is a worldwide nonprofit organization, which is dedicated to educating medical professionals in the use of radionuclide therapies based on the theragnostic principles and to harmonizing appropriate evidence‑based practices worldwide. | en_ZA |
dc.description.department | Nuclear Medicine | en_ZA |
dc.description.librarian | pm2020 | en_ZA |
dc.description.uri | http://www.wjnm.org | en_ZA |
dc.identifier.citation | Dizdarevic, S., Tulchinsky, M., McCready, V.R. et al. 2019, 'The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma', World Journal of Nuclear Medicine, vol. 18, no. 2, pp. 123-126. | en_ZA |
dc.identifier.issn | 1450-1147 (print) | |
dc.identifier.issn | 1607-3312 (online) | |
dc.identifier.other | 10.4103/wjnm.WJNM_117_18 | |
dc.identifier.uri | http://hdl.handle.net/2263/76135 | |
dc.language.iso | en | en_ZA |
dc.publisher | Medknow Publications | en_ZA |
dc.rights | © 2019 World Journal of Nuclear Medicine. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License. | en_ZA |
dc.subject | Cancer | en_ZA |
dc.subject | World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) | en_ZA |
dc.subject | Radioiodine therapy | en_ZA |
dc.subject | Thyroid carcinoma | en_ZA |
dc.title | The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma | en_ZA |
dc.type | Article | en_ZA |